Software for screening to assess risk of Down's syndrome.
作者信息
Reynolds T M
出版信息
BMJ. 1991 Apr 20;302(6782):965. doi: 10.1136/bmj.302.6782.965.
Abstract
摘要
相似文献
1
Software for screening to assess risk of Down's syndrome.用于筛查以评估唐氏综合征风险的软件。
BMJ. 1991 Apr 20;302(6782):965. doi: 10.1136/bmj.302.6782.965.
2
Estimations of gestational age and screening for Down's syndrome.孕周估算与唐氏综合征筛查。
BMJ. 1991 Apr 20;302(6782):965. doi: 10.1136/bmj.302.6782.965-a.
3
Accuracy of Down's syndrome risks produced in a prenatal screening program.
Ann Clin Biochem. 1999 Jan;36 ( Pt 1):101-3. doi: 10.1177/000456329903600115.
4
[Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].[孕中期使用母体血清生化指标进行唐氏综合征筛查方法的评估]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):332-5. doi: 10.3760/cma.j.issn.1003-9406.2011.03.021.
5
Assessment of atypicality: an adjunct to prenatal screening for Down's syndrome that facilitates detection of other abnormalities.
Ann Clin Biochem. 1993 Nov;30 ( Pt 6):578-83. doi: 10.1177/000456329303000609.
6
Down's syndrome screening is unethical: views of today's research ethics committees.唐氏综合征筛查是不道德的：当今研究伦理委员会的观点。
J Clin Pathol. 2003 Apr;56(4):268-70. doi: 10.1136/jcp.56.4.268.
7
Pregnant women support extra screening test for Down's syndrome.
BMJ. 2014 Sep 23;349:g5830. doi: 10.1136/bmj.g5830.
8
Down's syndrome screening in UK.
Lancet. 1996 Feb 3;347(8997):330. doi: 10.1016/s0140-6736(96)90507-3.
9
Influence of the software algorithm on risk calculation in Down's syndrome screening.
Clin Biochem. 2000 Nov;33(8):679-81. doi: 10.1016/s0009-9120(00)00176-4.
10
Atypicality or specific screen: which is better at detecting non-Down's chromosomal anomalies?非典型性筛查还是特异性筛查：哪种在检测非唐氏染色体异常方面更具优势？
Ann Clin Biochem. 1997 Nov;34 ( Pt 6):675-80. doi: 10.1177/000456329703400613.
引用本文的文献
1
2
Biochemical screening for Down's syndrome.唐氏综合征的生化筛查
BMJ. 1991 May 25;302(6787):1275. doi: 10.1136/bmj.302.6787.1275-c.
本文引用的文献
1
Maternal levels of pregnancy-specific beta 1-glycoprotein (SP-1) are elevated in pregnancies affected by Down's syndrome.在受唐氏综合征影响的妊娠中，母体血清妊娠特异性β1-糖蛋白（SP-1）水平会升高。
Hum Genet. 1988 Sep;80(1):46-8. doi: 10.1007/BF00451454.
2
Maternal serum screening for Down's syndrome in early pregnancy.孕早期唐氏综合征的母体血清筛查。
BMJ. 1988 Oct 8;297(6653):883-7. doi: 10.1136/bmj.297.6653.883.
3
Measurement of activity of urea resistant neutrophil alkaline phosphatase as an antenatal screening test for Down's syndrome.作为唐氏综合征产前筛查试验的耐尿素中性粒细胞碱性磷酸酶活性测定
BMJ. 1990 Nov 3;301(6759):1024-6. doi: 10.1136/bmj.301.6759.1024.
4
Maternal serum Down syndrome screening: unconjugated estriol is not useful.
Am J Obstet Gynecol. 1990 Mar;162(3):672-3. doi: 10.1016/0002-9378(90)90980-l.
5
ABC of antenatal care. Normal antenatal management.产前保健基础知识。正常产前管理。
BMJ. 1991 Mar 30;302(6779):774-9. doi: 10.1136/bmj.302.6779.774.
6
Potential prenatal predictions of Down syndrome: a statistical analysis.唐氏综合征的潜在产前预测：一项统计分析。
Am J Obstet Gynecol. 1990 Dec;163(6 Pt 1):1796-8. doi: 10.1016/0002-9378(90)90752-s.
Zotero 插件